No abstract available
MeSH terms
-
Acute Disease
-
Adolescent
-
Base Sequence
-
Biomarkers / analysis*
-
Bone Marrow Purging*
-
Bone Marrow Transplantation*
-
Busulfan*
-
Cell Separation
-
Child
-
Child, Preschool
-
Clinical Protocols
-
Combined Modality Therapy
-
Cyclophosphamide*
-
Drug Resistance
-
Evaluation Studies as Topic
-
Genetic Markers*
-
Genetic Vectors
-
Hematopoietic Stem Cells
-
Humans
-
Immunologic Factors
-
Infant
-
Informed Consent
-
Interleukin-2*
-
Kanamycin Kinase
-
Leukemia, Myeloid / drug therapy
-
Leukemia, Myeloid / genetics
-
Leukemia, Myeloid / pathology
-
Leukemia, Myeloid / therapy*
-
Mesna*
-
Molecular Sequence Data
-
Phosphotransferases (Alcohol Group Acceptor) / analysis
-
Phosphotransferases (Alcohol Group Acceptor) / genetics*
-
Recombinant Fusion Proteins
-
Remission Induction
-
Research Design
-
Retroviridae / genetics
-
Safety
-
Transplantation, Autologous
Substances
-
Biomarkers
-
Genetic Markers
-
Immunologic Factors
-
Interleukin-2
-
Recombinant Fusion Proteins
-
Cyclophosphamide
-
Phosphotransferases (Alcohol Group Acceptor)
-
Kanamycin Kinase
-
Busulfan
-
Mesna